Objective: To determine seroprotective antibody response after hepatitis B
vaccination during pregnancy and to assess factors influencing the rate of
maternal seroprotection.
Methods: Records of 80 healthy gravidas who elected hepatitis B vaccination
during pregnancy, after being identified as hepatitis B surface antigen (H
bsAg) and antibody (HbsAb) negative on initial prenatal screen, were analyz
ed retrospectively. Each gravida was begun on a series of three recombinant
hepatitis B vaccines at 0, 1, and 6 months. At 36-40 weeks' gestation, all
gravidas were rescreened for seroprotective levels of HbsAb using qualitat
ive enzyme-linked immunosorbent assay analysis. The women were grouped by m
aternal age (less than 25 years or at least 25 years), smoking history, mat
ernal weight, body mass index (BMI) (less than 30, at least 30, less than 3
4, or at least 34), number of vaccinations received, race-ethnicity, gestat
ional age at vaccination, and vaccination-to-rescreening interval. Data wer
e compared by t test, chi(2) test, or Fisher exact test. Stepwise logistic
regression analysis was done.
Results: At rescreening, 39 (49%) of the 80 women had seroprotective HbsAb
conversion. After two vaccinations, obese women (BMI at least 30) (P = .04)
, women at least 25 years old (P = .04), and women with smoking histories (
P = .005) were significantly less likely to respond to the vaccine. Logisti
c regression analysis for predicting failure of seroprotective response aft
er two vaccinations showed significantly increased odds for severe obesity
with BMI at least 34 (odds ratio [OR] 16.2; 95% confidence interval [CI] 1.
7, 154.7), smoking history (OR 7.5; 95% CI 2.0, 27.7), and age at least 25
years (OR 3.9; 95% CI 1.1, 14.4).
Conclusion: Maternal obesity, advancing age, and smoking have negative infl
uences on the efficacy of hepatitis B vaccination in pregnant women. (Obste
t Gynecol 1999;93: 983-6. (C) 1999 by The American College of Obstetricians
and Gynecologists.).